
Sign up to save your podcasts
Or


[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)
By NEJM Group4.5
5656 ratings
[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)

7,598 Listeners

320 Listeners

2,059 Listeners

125 Listeners

496 Listeners

293 Listeners

885 Listeners

263 Listeners

3,341 Listeners

112,022 Listeners

90 Listeners

5 Listeners

92 Listeners

513 Listeners

2,550 Listeners

369 Listeners

15,835 Listeners

61 Listeners

31 Listeners

66 Listeners